momo-T/FIF Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mopgcw who wrote (591)	7/7/2004 10:49:48 AM
From: scaram(o)uche	Read Replies (1) of 12215

antibody-dependent cellular cytotoxicity (I can use the "we")...... we've been trying to make it work for twenty years. When, after that period of time, something doesn't work? I usually lose interest. But ADC is different..... IMO it will eventually be THE route to survival, aggressive malignancies. the cell types that bear Fc receptors can be very mean suckers. if we can teach them to do tricks, it will be an enormous step. it may sometimes seem that I'm pessimistic regarding cancer immunology. that's not the case.... I'm just pessimistic about 98% of cancer immunology projects. btw.... too busy to post any longer, pseudobiologist had significant interest and up-to-date knowledge in this area. Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next